Position in MDXG
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,210,329
-$1,716,758 QoQ
Shares Held
812,742
+11.7% QoQ
Ownership
0.546%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 79.21874346348534.ToString("F0")%
Shared 0.ToString("F0")%
None 20.781256536514665.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. MDXG ranks #190 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in MDXG
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,210,329 | 812,742 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,927,087 | 727,783 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $5,233,294 | 749,756 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $6,477,721 | 1,060,184 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $8,246,506 | 1,085,067 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $10,508,557 | 1,092,366 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $6,796,779 | 1,150,048 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $9,195,482 | 1,326,910 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $14,849,968 | 1,928,568 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $13,923,188 | 1,587,593 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $11,498,754 | 1,577,333 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $8,317,056 | 1,258,254 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,527,472 | 447,940 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $549,372 | 197,617 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $366,808 | 127,809 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $823,329 | 237,272 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,290,334 | 273,957 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $923,012 | 152,817 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $900,860 | 148,657 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,590,393 | 207,066 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $724,213 | 70,312 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $548,722 | 60,432 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||